The future looks bright.
Wende
K E
KE
Department of Neurology, Buffalo General Hospital, NY, USA.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018450:Disease Progression; D005544:Forecasting; D000068717:Glatiramer Acetate; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D010455:Peptides / Q000627:therapeutic use; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta